Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals
Oren Milman, Idan Yelin, Noga Aharony, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1367-1369
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2108-2110
Open Access | Times Cited: 234
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 149
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
Lucy A. McNamara, Ryan E. Wiegand, Rachel M. Burke, et al.
The Lancet (2021) Vol. 399, Iss. 10320, pp. 152-160
Open Access | Times Cited: 82
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Ali Hamady, JinJu Lee, Zuzanna Loboda
Infection (2021) Vol. 50, Iss. 1, pp. 11-25
Open Access | Times Cited: 68
SARS-CoV-2 variants, immune escape, and countermeasures
Yi Zhang, Haocheng Zhang, Wenhong Zhang
Frontiers of Medicine (2022) Vol. 16, Iss. 2, pp. 196-207
Open Access | Times Cited: 65
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
V. Gounant, Valentine Marie Ferré, Ghassen Soussi, et al.
Journal of Thoracic Oncology (2021) Vol. 17, Iss. 2, pp. 239-251
Open Access | Times Cited: 61
Waning of SARS-CoV-2 booster viral-load reduction effectiveness
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Effectiveness of an Inactivated SARS-CoV-2 Vaccine
Annelies Wilder‐Smith, Kim Mulholland
New England Journal of Medicine (2021) Vol. 385, Iss. 10, pp. 946-948
Open Access | Times Cited: 59
The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers’ unvaccinated household members
Jussipekka Salo, Milla Hägg, Mika Kortelainen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Indirect protection of children from SARS-CoV-2 infection through parental vaccination
Samah Hayek, Galit Shaham, Yatir Ben‐Shlomo, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1155-1159
Open Access | Times Cited: 49
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain
Susana Monge, Carmen Olmedo, Belén Alejos, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 10, pp. 2595-2603
Open Access | Times Cited: 51
How will mass-vaccination change COVID-19 lockdown requirements in Australia?
Cameron Zachreson, Sheryl L. Chang, Oliver M. Cliff, et al.
The Lancet Regional Health - Western Pacific (2021) Vol. 14, pp. 100224-100224
Open Access | Times Cited: 46
SARS-CoV-2 Vaccines: Where Are We Now?
Katie L. Flanagan, C. Raina MacIntyre, Peter McIntyre, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 10, pp. 3535-3543
Open Access | Times Cited: 43
Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study
Iván Martínez‐Baz, Ana Miqueleiz, Nerea Egüés, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 3, pp. 410-417
Open Access | Times Cited: 16
Quantitative observational evidence of indirect herd benefits from COVID-19 vaccination or prior infection on SARS-CoV-2 infections and COVID-19 deaths: a population-based retrospective cohort study in Ontario, Canada
Linwei Wang, Sarah Swayze, Arjumand Siddiqi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Who is likely to vacillate in their COVID-19 vaccination decision? Free-riding intention and post-positive reluctance
Marta Caserotti, Teresa Gavaruzzi, Paolo Girardi, et al.
Preventive Medicine (2021) Vol. 154, pp. 106885-106885
Open Access | Times Cited: 34
SARS-CoV-2: The Monster Causes COVID-19
Chang Song, Zesong Li, Chen Li, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 23
Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters
Tamarand L. Darling, Houda Harastani, Astha Joshi, et al.
Science Advances (2024) Vol. 10, Iss. 31
Open Access | Times Cited: 4
The indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members
Jussipekka Salo, Milla Hägg, Mika Kortelainen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper
Grigoris T. Gerotziafas, M. Catalano, Yiannis Theodorou, et al.
Thrombosis and Haemostasis (2021) Vol. 121, Iss. 08, pp. 992-1007
Open Access | Times Cited: 27
Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example
Tinevimbo Shiri, Marc Evans, Carla Talarico, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1180-1180
Open Access | Times Cited: 25
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern
Tianhong Xie, Shuaiyao Lu, Zhanlong He, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 18
Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top